Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1384-1385. doi: 10.1016/j.jaip.2020.09.007. Epub 2020 Sep 19.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Aspirin* / adverse effects
  • Asthma, Aspirin-Induced* / diagnosis
  • Asthma, Aspirin-Induced* / drug therapy
  • Humans

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal, Humanized
  • mepolizumab
  • Aspirin